View our presentation on myOLARIS-KTdx™ at the American Transplant Congress 2022 meeting:
Using a proprietary metabolite profiling platform and customized machine learning algorithms, Olaris Cerebro can identify individual molecular profiles to improve diagnosis and treatment of diseases. This data enables patients and their healthcare providers to pursue the most effective treatments.
OLARIS CEREBRO COMBINES METABOLITES & MACHINE LEARNING
We believe the future of medicine includes precision diagnostics that combine metabolomics, biophysics, machine learning and biology to optimize patient outcomes
While others outsource parts of this process, our end-to-end solution offers full control, complex integration and scalability to repeatedly deliver clinical insights
Our tech advantage comes from combining proprietary metabolic profiling technology, custom machine learning algorithms, and connections to real-world clinical data
FACTORS BEYOND GENETICS INFLUENCE DRUG RESPONSE
Beyond genetics, many factors influence an individual's health, affecting disease development and drug response.
Olaris Cerebro identifies biomarkers of response to differentiate between individuals likely vs. unlikely to develop a disease, or those likely vs. unlikely to benefit from a specific drug.